LabelIt seems the most likely label would be "cis containing, bcg refractory, unwilimg or unable to undergo cystecomy."
but the adcom seemed not to adress question 3a, therefore i didnt find trough the transcript a clear comment in favor of that label. In their final decision adcom member only commented on the "unwiling or unable". M80 my question is WHY
also, a new chemotherapy "myocyclin" treatment just came out and have better effect on papilary cancer than BCG, so i think it supports my view on the CiS label
again m80, any comment?